Arnulfo Mendoza Selected Research

Arnulfo Mendoza Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 02/2004
16	Neoplasm Metastasis (Metastasis) 02/2023 - 02/2004
12	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 02/2004
9	Ewing Sarcoma (Sarcoma, Ewing) 04/2024 - 06/2008
7	Rhabdomyosarcoma 11/2023 - 05/2006
5	Sarcoma (Soft Tissue Sarcoma) 02/2019 - 12/2007
3	Neuroblastoma 01/2021 - 11/2015
3	Carcinogenesis 01/2020 - 11/2009
2	Melanoma (Melanoma, Malignant) 02/2023 - 01/2008
2	Breast Neoplasms (Breast Cancer) 01/2014 - 12/2007
1	Necrosis 11/2023
1	Embryonal Rhabdomyosarcoma 01/2020
1	Adenocarcinoma 11/2016
1	Werner Syndrome (Werner's Syndrome) 03/2014
1	Fibrosis (Cirrhosis) 01/2014
1	Genetic Translocation (Chromosomal Translocation) 06/2011
1	Leukemia 06/2011
1	Obesity 01/2010
1	Colorectal Neoplasms (Colorectal Cancer) 01/2010
1	Inflammation (Inflammations) 01/2010

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2016 - 05/2006
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2014
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 06/2011
4	Small Interfering RNA (siRNA)IBA 10/2019 - 03/2014
3	NAD (NADH)IBA 11/2023 - 01/2020
3	Nicotinamide PhosphoribosyltransferaseIBA 09/2020 - 12/2017
3	EWS-FLI fusion proteinIBA 01/2020 - 03/2014
3	ezrinIBA 02/2012 - 02/2004
2	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 03/2014
2	OT-82IBA 11/2023 - 09/2020
2	trametinibIBA 01/2021 - 01/2018
2	EnzymesIBA 01/2020 - 10/2019
2	NucleotidesIBA 01/2020 - 02/2019
2	Glucose (Dextrose)FDA LinkGeneric 02/2019 - 11/2016
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018 - 01/2009
2	Sirolimus (Rapamycin)FDA Link 12/2016 - 03/2005
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016 - 11/2009
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2010 - 05/2009
1	AZD7648IBA 04/2024
1	Etoposide (VP 16)FDA LinkGeneric 04/2024
1	DNA-Activated Protein KinaseIBA 04/2024
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 02/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2023
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 02/2023
1	LipidsIBA 02/2023
1	Vinca AlkaloidsIBA 01/2021
1	ON 01910IBA 01/2021
1	Serine (L-Serine)FDA Link 01/2020
1	NCT-503IBA 01/2020
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 01/2020
1	MyoD ProteinIBA 01/2020
1	Drug CombinationsIBA 01/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 10/2019
1	SurvivinIBA 10/2019
1	Lactate Dehydrogenase 5IBA 10/2019
1	ChromatinIBA 10/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2019
1	Glutamine (L-Glutamine)FDA Link 02/2019
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 02/2019
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Thromboplastin (Tissue Factor)IBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2017
1	Inositol (Myoinositol)IBA 06/2017
1	Messenger RNA (mRNA)IBA 12/2016
1	Somatomedin Receptors (Somatomedin Receptor)IBA 12/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 11/2016
1	STA-12-8666IBA 10/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2016
1	Topoisomerase I InhibitorsIBA 10/2016
1	Aurora Kinase BIBA 11/2015
1	teprotumumabIBA 04/2015
1	src-Family KinasesIBA 04/2015
1	BMS 754807IBA 04/2015
1	Biomarkers (Surrogate Marker)IBA 04/2015
1	Insulin-Like PeptidesIBA 04/2015
1	Phosphotransferases (Kinase)IBA 04/2015
1	CamptothecinIBA 03/2014
1	TrabectedinIBA 03/2014
1	CollagenIBA 01/2014
1	Fibronectins (Fibronectin)IBA 01/2014
1	Amino Acids FDA Link 02/2012
1	Plicamycin FDA Link 06/2011
1	Insulin (Novolin)FDA Link 01/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2009
1	Busulfan (Busulfex)FDA Link 06/2008
1	Bisbenzimidazole (Hoechst 33258)IBA 06/2008
1	Annexin A5IBA 06/2008
1	Alkylating AgentsIBA 06/2008
1	treosulfanIBA 06/2008
1	Chemokine CXCL12IBA 01/2008
1	LigandsIBA 01/2008
1	Chemokine ReceptorsIBA 01/2008

Therapy/Procedure

12	Therapeutics 11/2023 - 01/2008
3	Drug Therapy (Chemotherapy) 04/2024 - 06/2008
1	Treatment Delay 01/2021
1	Intravenous Administration 10/2019
1	Combined Modality Therapy 11/2015